Literature DB >> 16942489

Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya.

Judie B Alimonti1, Joshua Kimani, Lucy Matu, Charles Wachihi, Rupert Kaul, Francis A Plummer, Keith R Fowke.   

Abstract

CD8+ T-lymphocyte responses are crucial to the control of HIV-1; therefore, studying the CD8+ immune response in a naturally resistant population could provide valuable insights into an effective anti-HIV response in healthy uninfected individuals. Approximately 5-10% of the women in the Pumwani Commercial Sex Worker cohort in Nairobi, Kenya, have been highly exposed to HIV-1 yet remain HIV-IgG-seronegative and HIV-PCR negative (HIV(ES)). As IFN-gamma production correlates to cytotoxic function, the CD8+ T-lymphocyte IFN-gamma response to HIV p24 peptides was compared in HIV(ES) and HIV-infected (HIV+) individuals. Almost 40% of the HIV(ES) had a CD8+ IFN-gamma+ response that was five times lower in magnitude than that of the HIV+ group. The breadth of the response in HIV(ES) was very narrow and focused primarily on one peptide that is similar to the protective KK10 peptide. In the HIV+ group, low peripheral CD4+ counts negatively influenced the number of CD8+ cells producing IFN-gamma, which may undermine the ability to control HIV. Overall, many of the HIV(ES) women possess a HIV-1 p24-specific CD8+ IFN-gamma response, providing evidence to the specificity needed for an effective HIV vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16942489     DOI: 10.1111/j.1440-1711.2006.01455.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  29 in total

1.  For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.

Authors:  Ma Luo; Christina A Daniuk; Tamsir O Diallo; Rupert E Capina; Joshua Kimani; Charles Wachihi; Makubo Kimani; Thomas Bielawny; Trevor Peterson; Mark G R Mendoza; Sandra Kiazyk; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals.

Authors:  Laura Pattacini; Pamela M Murnane; Erin M Kahle; Michael J Bolton; Jeffrey J Delrow; Jairam R Lingappa; Elly Katabira; Deborah Donnell; M Juliana McElrath; Jared M Baeten; Jennifer M Lund
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-30       Impact factor: 2.205

3.  HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls.

Authors:  Brandon L Guthrie; Barbara Lohman-Payne; Amy Y Liu; Rose Bosire; Samuel Victor Nuvor; Robert Y Choi; Romel D Mackelprang; James N Kiarie; Stephen C De Rosa; Barbra A Richardson; Grace C John-Stewart; Carey Farquhar
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

4.  Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals.

Authors:  Ruey-Chyi Su; Aida Sivro; Joshua Kimani; Walter Jaoko; Francis A Plummer; T Blake Ball
Journal:  Blood       Date:  2011-01-03       Impact factor: 22.113

5.  Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt.

Authors:  Salwa S Seif Eldin; Ismail Seddik; Enas A Daef; M T Shata; Marwa Raafat; Laila Abdel Baky; M A Nafeh
Journal:  Egypt J Immunol       Date:  2010

Review 6.  Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).

Authors:  C Tomescu; S Abdulhaqq; L J Montaner
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

7.  Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons.

Authors:  Laura Pattacini; Pamela M Murnane; Jared M Baeten; Tayler R Fluharty; Katherine K Thomas; Elizabeth Bukusi; Elly Katabira; Nelly Mugo; Deborah Donnell; Jairam R Lingappa; Connie Celum; Mark Marzinke; M Juliana McElrath; Jennifer M Lund
Journal:  J Infect Dis       Date:  2014-12-17       Impact factor: 5.226

8.  Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

Authors:  Mohamed Hashem; Hanaa El-Karaksy; Mohamed T Shata; Maha Sobhy; Heba Helmy; Suzan El-Naghi; Gehan Galal; Zainab Z Ali; Gamal Esmat; Sayed F Abdelwahab; G Thomas Strickland; Samer S El-Kamary
Journal:  J Infect Dis       Date:  2011-01-21       Impact factor: 5.226

9.  A genetic polymorphism of FREM1 is associated with resistance against HIV infection in the Pumwani sex worker cohort.

Authors:  Ma Luo; James Sainsbury; Jeffrey Tuff; Philip A Lacap; Xin-Yong Yuan; Taha Hirbod; Joshua Kimani; Charles Wachihi; Sue Ramdahin; Thomas Bielawny; Joanne Embree; Kristina Broliden; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

10.  Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection.

Authors:  Hongzhao Li; Robert W Omange; Binhua Liang; Nikki Toledo; Yan Hai; Lewis R Liu; Dane Schalk; Jose Crecente-Campo; Tamara G Dacoba; Andrew B Lambe; So-Yon Lim; Lin Li; Mohammad Abul Kashem; Yanmin Wan; Jorge F Correia-Pinto; Michael S Seaman; Xiao Qing Liu; Robert F Balshaw; Qingsheng Li; Nancy Schultz-Darken; Maria J Alonso; Francis A Plummer; James B Whitney; Ma Luo
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.